The Brazilian Health Regulatory Agency (ANVISA) has issued a communication reaffirming the requirement for pharmaceutical companies to comply with updated labeling standards for medicines registered under the simplified notification pathway. This reminder highlights the upcoming final compliance deadline of 30 December 2025, by which all such products must fully align with Brazil’s updated labeling regulations.
The announcement aims to ensure that companies are aware of the regulatory expectations and timelines associated with label updates, artwork revisions, and documentation requirements.
Objective of the Guidance
ANVISA’s communication is intended to guide stakeholders in meeting the compulsory labeling alignment by the end of 2025. This applies to:
Medicinal products under simplified notification
Updated labeling content requirements, including mandatory statements, warnings, storage directions, and product identification elements
Processes and documentation, ensuring companies maintain appropriate internal records supporting compliance
Key Considerations Covered
The regulatory update emphasizes that:
All new submissions made on or after 30 December 2025 must include labels updated per the new rules.
As ANVISA’s digital notification system does not yet support secondary petitions solely for label layout changes, companies must retain internal documentation demonstrating that their updated labels meet the required criteria.
Effective compliance will require coordinated efforts across regulatory, quality, labeling, and manufacturing teams to ensure artwork updates, SOP revisions, and inventory management processes support timely implementation.
Regulatory Commitment and Context
ANVISA’s reminder reinforces its broader goal of:
- Standardizing labeling requirements across Brazil’s pharmaceutical sector
- Ensuring clarity, transparency, and safety for end users through consistent label information
- Driving industry adherence to the updated labeling framework by the mandated deadline of 30 December 2025
- Promoting a more harmonized regulatory environment aligned with Brazil’s labeling modernization initiatives
Select Mandate HA
Select Mandate Function